.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Farmers Insurance
Fuji
Moodys
US Army
Boehringer Ingelheim
Harvard Business School
Baxter
Accenture
Medtronic

Generated: December 12, 2017

DrugPatentWatch Database Preview

Haloperidol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for haloperidol and what is the scope of haloperidol patent protection?

Haloperidol
is the generic ingredient in six branded drugs marketed by Ortho Mcneil, Ortho Mcneil Pharm, Anda Repository, Cycle Pharms Ltd, Duramed Pharms Barr, Lederle, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sandoz, SCS, Vintage, Watson Labs, Zydus Pharms Usa, Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sandoz Inc, Teva Pharms Usa, West-ward Pharms Int, Alpharma, Morton Grove, Pharm Assoc, Silarx, Teva, Teva Pharms, Abraxis Pharm, Akorn, Baxter Hlthcare Corp, Marsam Pharms Llc, Sagent Pharms, Smith And Nephew, Solopak, and Actavis Mid Atlantic, and is included in one hundred and eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol. Twenty-three suppliers are listed for this compound.

Pharmacology for haloperidol

Medical Subject Heading (MeSH) Categories for haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Royce LabsHALOPERIDOLhaloperidolTABLET;ORAL071724-001Dec 24, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Labs LtdHALOPERIDOL DECANOATEhaloperidol decanoateINJECTABLE;INJECTION075440-002Feb 28, 2000AORXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ortho McneilHALDOLhaloperidolTABLET;ORAL015921-006Feb 2, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
ScsHALOPERIDOLhaloperidol lactateCONCENTRATE;ORAL070726-001Jun 10, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sagent PharmsHALOPERIDOLhaloperidol lactateINJECTABLE;INJECTION091637-001Sep 2, 2011APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Duramed Pharms BarrHALOPERIDOLhaloperidolTABLET;ORAL071219-001Dec 4, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Quantum PharmicsHALOPERIDOLhaloperidolTABLET;ORAL071269-001Feb 17, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsHALOPERIDOLhaloperidolTABLET;ORAL071573-001Jun 3, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozHALOPERIDOLhaloperidolTABLET;ORAL071206-001Nov 17, 1986ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanHALOPERIDOLhaloperidolTABLET;ORAL070278-001Jun 10, 1986ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho McneilHALDOLhaloperidolTABLET;ORAL015921-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho McneilHALDOLhaloperidolTABLET;ORAL015921-006Feb 2, 1982► Subscribe► Subscribe
Ortho McneilHALDOLhaloperidolTABLET;ORAL015921-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho McneilHALDOLhaloperidolTABLET;ORAL015921-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho McneilHALDOLhaloperidolTABLET;ORAL015921-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho McneilHALDOLhaloperidolTABLET;ORAL015921-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
McKinsey
US Department of Justice
Covington
Deloitte
Teva
McKesson
Argus Health
Cerilliant
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot